105 related articles for article (PubMed ID: 11720457)
1. Adjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice.
Bouchardy C; Queneau PE; Fioretta G; Usel M; Zellweger M; Neyroud I; Raymond L; de Wolf C; Sappino AP
Br J Cancer; 2001 Nov; 85(9):1251-7. PubMed ID: 11720457
[TBL] [Abstract][Full Text] [Related]
2. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI
Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for stage II colon cancer: influence of care structures' characteristics on a controversial clinical practice.
Alter E; Phelip JM; Guilhot JN; Matysiak M; Vermorel M; Roblin X
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):995-1001. PubMed ID: 18049170
[TBL] [Abstract][Full Text] [Related]
4. Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice.
Ananda S; Field KM; Kosmider S; Compston D; Desai J; Lim LC; Barnett FS; Jones IT; Skinner I; Gibbs P
J Clin Oncol; 2008 Sep; 26(27):4516-7; author reply 4517-8. PubMed ID: 18802167
[No Abstract] [Full Text] [Related]
5. Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer.
Earle CC; Weiser MR; Ter Veer A; Skibber JM; Wilson J; Rajput A; Wong YN; Benson AB; Shibata S; Romanus D; Niland J; Schrag D
J Surg Oncol; 2009 Dec; 100(7):525-8. PubMed ID: 19697351
[TBL] [Abstract][Full Text] [Related]
6. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
[TBL] [Abstract][Full Text] [Related]
7. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
8. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
[TBL] [Abstract][Full Text] [Related]
9. Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana.
Wu X; Chen VW; Andrews PA; Chen L; Hsieh M; Fontham ET
J La State Med Soc; 2004; 156(5):255-61. PubMed ID: 15554095
[TBL] [Abstract][Full Text] [Related]
10. Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study.
Sundararajan V; Grann VR; Jacobson JS; Ahsan H; Neugut AI
Cancer J; 2001; 7(3):213-8. PubMed ID: 11419029
[TBL] [Abstract][Full Text] [Related]
11. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
[TBL] [Abstract][Full Text] [Related]
12. Survival and time interval from surgery to start of chemotherapy among colon cancer patients.
Zeig-Owens R; Gershman ST; Knowlton R; Jacobson JS
J Registry Manag; 2009; 36(2):30-41; quiz 61-2. PubMed ID: 19694115
[TBL] [Abstract][Full Text] [Related]
13. A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers.
Phelip JM; Molinié F; Delafosse P; Launoy G; Trétarre B; Bara S; Buémi A; Velten M; Danzon A; Ganry O; Bouvier AM; Grosclaude P; Faivre J
Gastroenterol Clin Biol; 2010 Feb; 34(2):144-9. PubMed ID: 20079591
[TBL] [Abstract][Full Text] [Related]
14. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Meyerhardt JA; Heseltine D; Niedzwiecki D; Hollis D; Saltz LB; Mayer RJ; Thomas J; Nelson H; Whittom R; Hantel A; Schilsky RL; Fuchs CS
J Clin Oncol; 2006 Aug; 24(22):3535-41. PubMed ID: 16822843
[TBL] [Abstract][Full Text] [Related]
15. Are many community hospitals undertreating breast cancer?: lessons from 24,834 patients.
Gutierrez JC; Hurley JD; Housri N; Perez EA; Byrne MM; Koniaris LG
Ann Surg; 2008 Aug; 248(2):154-62. PubMed ID: 18650623
[TBL] [Abstract][Full Text] [Related]
16. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved.
Tsikitis VL; Larson DL; Wolff BG; Kennedy G; Diehl N; Qin R; Dozois EJ; Cima RR
J Am Coll Surg; 2009 Jan; 208(1):42-7. PubMed ID: 19228501
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.
Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N
J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma.
Lee HY; Choi HJ; Park KJ; Shin JS; Kwon HC; Roh MS; Kim C
Ann Surg Oncol; 2007 May; 14(5):1712-7. PubMed ID: 17253102
[TBL] [Abstract][Full Text] [Related]
19. Young age influences treatment but not outcome of colon cancer.
Quah HM; Joseph R; Schrag D; Shia J; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Ann Surg Oncol; 2007 Oct; 14(10):2759-65. PubMed ID: 17593332
[TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
